IGC Pharma (IGC) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2017)
IGC Pharma (IGC) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2017 |
26.32% |
| Sep 30, 2017 |
47.72% |
| Jun 30, 2017 |
44.97% |
| Mar 31, 2017 |
43.91% |
| Dec 31, 2016 |
48.90% |
| Sep 30, 2016 |
39.43% |
| Jun 30, 2016 |
39.43% |
| Mar 31, 2016 |
32.49% |
| Dec 31, 2015 |
-33.89% |
| Sep 30, 2015 |
-25.99% |
| Jun 30, 2015 |
40.16% |
| Mar 31, 2015 |
66.94% |
| Dec 31, 2014 |
17.79% |
| Sep 30, 2014 |
-20.51% |
| Jun 30, 2014 |
-44.22% |
| Mar 31, 2014 |
47.55% |
| Sep 30, 2013 |
-14.47% |
| Jun 30, 2013 |
-21.64% |
